Built for Rare. Powered by Insight.

swii.ch is a strategic consultancy that helps biopharma teams solve the hardest problems in rare disease — from early patient identification to EU JCA readiness. We combine behavioural science, digital innovation, and regulatory fluency to deliver insight-led solutions that accelerate access, build trust, and empower patients

Our Mission

To improve outcomes in rare disease by helping our clients move faster, smarter, and more ethically — through strategy, systems, and co-creation.

What Makes Us Different

Strategic, Not Tactical
We don’t just deliver services — we design systems. Our work is grounded in strategic thinking, not just execution.

Rare Disease Is Our Focus
We work exclusively in rare disease. That means we understand the complexity, urgency, and nuance that generalist agencies often miss.

Digital + Behavioural Science
We use behavioural insights and digital tools to uncover hidden patient populations, activate communities, and support smarter decision-making.

Built for Cross-Border Complexity
From EU JCA to global advocacy alignment, we help you navigate regulatory, cultural, and operational complexity with clarity.

Who We Work With

We partner with:
– Emerging biotechs preparing for launch
– Global pharma teams navigating EU JCA
– Medical affairs and market access leaders
– Patient engagement and advocacy teams

Our clients trust us to bring clarity to complexity — and to keep patients at the centre of every solution.

Let’s Build Something Better

Whether you’re preparing for HTA submission, designing a digital advocacy program, or trying to find the right patients faster — we’re here to help..

We use cookies in order to give you the best possible experience on our website. By continuing to use this site, you agree to our use of cookies.
Accept